Table of Content

1 Study Coverage
1.1 Cell and Gene Therapy CDMO Product Introduction
1.2 Global Cell and Gene Therapy CDMO Outlook 2018 VS 2022 VS 2033
1.2.1 Global Cell and Gene Therapy CDMO Market Size for the Year 2018-2033
1.2.2 India Cell and Gene Therapy CDMO Market Size for the Year 2018-2033
1.3 Cell and Gene Therapy CDMO Market Size, India VS Global, 2018 VS 2022 VS 2033
1.3.1 The Market Share of India Cell and Gene Therapy CDMO in Global, 2018 VS 2022 VS 2033
1.3.2 The Growth Rate of Cell and Gene Therapy CDMO Market Size, India VS Global, 2018 VS 2022 VS 2033
1.4 Cell and Gene Therapy CDMO Market Dynamics
1.4.1 Cell and Gene Therapy CDMO Industry Trends
1.4.2 Cell and Gene Therapy CDMO Market Drivers
1.4.3 Cell and Gene Therapy CDMO Market Challenges
1.4.4 Cell and Gene Therapy CDMO Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Cell and Gene Therapy CDMO by Type
2.1 Cell and Gene Therapy CDMO Market Segment by Type
2.1.1 Clinical Trial Material CDMOs
2.1.2 Development and Manufacturing CDMOs
2.1.3 Other
2.2 Global Cell and Gene Therapy CDMO Market Size by Type (2018, 2022 & 2033)
2.3 Global Cell and Gene Therapy CDMO Market Size by Type (2018-2033)
2.4 India Cell and Gene Therapy CDMO Market Size by Type (2018, 2022 & 2033)
2.5 India Cell and Gene Therapy CDMO Market Size by Type (2018-2033)
3 Cell and Gene Therapy CDMO by Application
3.1 Cell and Gene Therapy CDMO Market Segment by Application
3.1.1 Pharmaceutical Company
3.1.2 Biotechnology Company
3.1.3 Other
3.2 Global Cell and Gene Therapy CDMO Market Size by Application (2018, 2022 & 2033)
3.3 Global Cell and Gene Therapy CDMO Market Size by Application (2018-2033)
3.4 India Cell and Gene Therapy CDMO Market Size by Application (2018, 2022 & 2033)
3.5 India Cell and Gene Therapy CDMO Market Size by Application (2018-2033)
4 Global Cell and Gene Therapy CDMO Competitor Landscape by Company
4.1 Global Cell and Gene Therapy CDMO Market Size by Company
4.1.1 Global Key Companies of Cell and Gene Therapy CDMO, Ranked by Revenue (2022)
4.1.2 Global Cell and Gene Therapy CDMO Revenue by Player (2018-2023)
4.2 Global Cell and Gene Therapy CDMO Concentration Ratio (CR)
4.2.1 Cell and Gene Therapy CDMO Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of Cell and Gene Therapy CDMO in 2022
4.2.3 Global Cell and Gene Therapy CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Cell and Gene Therapy CDMO Head office and Area Served
4.4 Global Key Players of Cell and Gene Therapy CDMO, Product and Application
4.5 Global Key Players of Cell and Gene Therapy CDMO, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 India Cell and Gene Therapy CDMO Market Size by Company
4.7.1 Key Players of Cell and Gene Therapy CDMO in India, Ranked by Revenue (2022)
4.7.2 India Cell and Gene Therapy CDMO Revenue by Players (2021, 2022 & 2023)
5 Global Cell and Gene Therapy CDMO Market Size by Region
5.1 Global Cell and Gene Therapy CDMO Market Size by Region: 2018 VS 2022 VS 2033
5.2 Global Cell and Gene Therapy CDMO Market Size by Region (2018-2033)
5.2.1 Global Cell and Gene Therapy CDMO Market Size by Region: 2018-2023
5.2.2 Global Cell and Gene Therapy CDMO Market Size by Region (2024-2033)
6 Americas
6.1 Americas Cell and Gene Therapy CDMO Market Size YoY Growth 2018-2033
6.2 Americas Cell and Gene Therapy CDMO Market Size by Type
6.2.1 Americas Cell and Gene Therapy CDMO Market Size by Type (2018-2023)
6.2.2 Americas Cell and Gene Therapy CDMO Market Size by Type (2024-2033)
6.2.3 Americas Cell and Gene Therapy CDMO Market Share by Type (2018-2033)
6.3 Americas Cell and Gene Therapy CDMO Market Size by Application
6.3.1 Americas Cell and Gene Therapy CDMO Market Size by Application (2018-2023)
6.3.2 Americas Cell and Gene Therapy CDMO Market Size by Application (2024-2033)
6.3.3 Americas Cell and Gene Therapy CDMO Market Share by Application (2018-2033)
6.4 Americas Cell and Gene Therapy CDMO Market Facts & Figures by Country (2018, 2022 & 2033)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Cell and Gene Therapy CDMO Market Size YoY Growth 2018-2033
7.2 EMEA Cell and Gene Therapy CDMO Market Size by Type
7.2.1 EMEA Cell and Gene Therapy CDMO Market Size by Type (2018-2023)
7.2.2 EMEA Cell and Gene Therapy CDMO Market Size by Type (2024-2033)
7.2.3 EMEA Cell and Gene Therapy CDMO Market Share by Type (2018-2033)
7.3 EMEA Cell and Gene Therapy CDMO Market Size by Application
7.3.1 EMEA Cell and Gene Therapy CDMO Market Size by Application (2018-2023)
7.3.2 EMEA Cell and Gene Therapy CDMO Market Size by Application (2024-2033)
7.3.3 EMEA Cell and Gene Therapy CDMO Market Share by Application (2018-2033)
7.4 EMEA Cell and Gene Therapy CDMO Market Facts & Figures by Country (2018, 2022 & 2033)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Cell and Gene Therapy CDMO Market Size YoY Growth 2018-2033
8.2 China Cell and Gene Therapy CDMO Market Size by Type
8.2.1 China Cell and Gene Therapy CDMO Market Size by Type (2018-2023)
8.2.2 China Cell and Gene Therapy CDMO Market Size by Type (2024-2033)
8.2.3 China Cell and Gene Therapy CDMO Market Share by Type (2018-2033)
8.3 China Cell and Gene Therapy CDMO Market Size by Application
8.3.1 China Cell and Gene Therapy CDMO Market Size by Application (2018-2023)
8.3.2 China Cell and Gene Therapy CDMO Market Size by Application (2024-2033)
8.3.3 China Cell and Gene Therapy CDMO Market Share by Application (2018-2033)
9 APAC (excluding China)
9.1 APAC Cell and Gene Therapy CDMO Market Size YoY Growth 2018-2033
9.2 APAC Cell and Gene Therapy CDMO Market Size by Type
9.2.1 APAC Cell and Gene Therapy CDMO Market Size by Type (2018-2023)
9.2.2 APAC Cell and Gene Therapy CDMO Market Size by Type (2024-2033)
9.2.3 APAC Cell and Gene Therapy CDMO Market Share by Type (2018-2033)
9.3 APAC Cell and Gene Therapy CDMO Market Size by Application
9.3.1 APAC Cell and Gene Therapy CDMO Market Size by Application (2018-2023)
9.3.2 APAC Cell and Gene Therapy CDMO Market Size by Application (2024-2033)
9.3.3 APAC Cell and Gene Therapy CDMO Market Share by Application (2018-2033)
9.4 APAC Cell and Gene Therapy CDMO Market Facts & Figures by Country (2018, 2022 & 2033)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 Lonza
10.1.1 Lonza Company Details
10.1.2 Lonza Business Overview
10.1.3 Lonza Cell and Gene Therapy CDMO Introduction
10.1.4 Lonza Revenue in Cell and Gene Therapy CDMO Business (2018-2023)
10.1.5 Lonza Recent Development
10.2 Charles River Laboratories
10.2.1 Charles River Laboratories Company Details
10.2.2 Charles River Laboratories Business Overview
10.2.3 Charles River Laboratories Cell and Gene Therapy CDMO Introduction
10.2.4 Charles River Laboratories Revenue in Cell and Gene Therapy CDMO Business (2018-2023)
10.2.5 Charles River Laboratories Recent Development
10.3 Cytiva
10.3.1 Cytiva Company Details
10.3.2 Cytiva Business Overview
10.3.3 Cytiva Cell and Gene Therapy CDMO Introduction
10.3.4 Cytiva Revenue in Cell and Gene Therapy CDMO Business (2018-2023)
10.3.5 Cytiva Recent Development
10.4 Catalent Biologics
10.4.1 Catalent Biologics Company Details
10.4.2 Catalent Biologics Business Overview
10.4.3 Catalent Biologics Cell and Gene Therapy CDMO Introduction
10.4.4 Catalent Biologics Revenue in Cell and Gene Therapy CDMO Business (2018-2023)
10.4.5 Catalent Biologics Recent Development
10.5 FUJIFILM Diosynth Biotechnologies
10.5.1 FUJIFILM Diosynth Biotechnologies Company Details
10.5.2 FUJIFILM Diosynth Biotechnologies Business Overview
10.5.3 FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy CDMO Introduction
10.5.4 FUJIFILM Diosynth Biotechnologies Revenue in Cell and Gene Therapy CDMO Business (2018-2023)
10.5.5 FUJIFILM Diosynth Biotechnologies Recent Development
10.6 BioCentriq
10.6.1 BioCentriq Company Details
10.6.2 BioCentriq Business Overview
10.6.3 BioCentriq Cell and Gene Therapy CDMO Introduction
10.6.4 BioCentriq Revenue in Cell and Gene Therapy CDMO Business (2018-2023)
10.6.5 BioCentriq Recent Development
10.7 RoslinCT
10.7.1 RoslinCT Company Details
10.7.2 RoslinCT Business Overview
10.7.3 RoslinCT Cell and Gene Therapy CDMO Introduction
10.7.4 RoslinCT Revenue in Cell and Gene Therapy CDMO Business (2018-2023)
10.7.5 RoslinCT Recent Development
10.8 Thermo Scientific
10.8.1 Thermo Scientific Company Details
10.8.2 Thermo Scientific Business Overview
10.8.3 Thermo Scientific Cell and Gene Therapy CDMO Introduction
10.8.4 Thermo Scientific Revenue in Cell and Gene Therapy CDMO Business (2018-2023)
10.8.5 Thermo Scientific Recent Development
10.9 Mesoblast
10.9.1 Mesoblast Company Details
10.9.2 Mesoblast Business Overview
10.9.3 Mesoblast Cell and Gene Therapy CDMO Introduction
10.9.4 Mesoblast Revenue in Cell and Gene Therapy CDMO Business (2018-2023)
10.9.5 Mesoblast Recent Development
10.10 Cellularity
10.10.1 Cellularity Company Details
10.10.2 Cellularity Business Overview
10.10.3 Cellularity Cell and Gene Therapy CDMO Introduction
10.10.4 Cellularity Revenue in Cell and Gene Therapy CDMO Business (2018-2023)
10.10.5 Cellularity Recent Development
10.11 Bluebird Bio
10.11.1 Bluebird Bio Company Details
10.11.2 Bluebird Bio Business Overview
10.11.3 Bluebird Bio Cell and Gene Therapy CDMO Introduction
10.11.4 Bluebird Bio Revenue in Cell and Gene Therapy CDMO Business (2018-2023)
10.11.5 Bluebird Bio Recent Development
10.12 Editas Medicine
10.12.1 Editas Medicine Company Details
10.12.2 Editas Medicine Business Overview
10.12.3 Editas Medicine Cell and Gene Therapy CDMO Introduction
10.12.4 Editas Medicine Revenue in Cell and Gene Therapy CDMO Business (2018-2023)
10.12.5 Editas Medicine Recent Development
10.13 Andelyn Biosciences
10.13.1 Andelyn Biosciences Company Details
10.13.2 Andelyn Biosciences Business Overview
10.13.3 Andelyn Biosciences Cell and Gene Therapy CDMO Introduction
10.13.4 Andelyn Biosciences Revenue in Cell and Gene Therapy CDMO Business (2018-2023)
10.13.5 Andelyn Biosciences Recent Development
10.14 Wuxi Advanced Therapies
10.14.1 Wuxi Advanced Therapies Company Details
10.14.2 Wuxi Advanced Therapies Business Overview
10.14.3 Wuxi Advanced Therapies Cell and Gene Therapy CDMO Introduction
10.14.4 Wuxi Advanced Therapies Revenue in Cell and Gene Therapy CDMO Business (2018-2023)
10.14.5 Wuxi Advanced Therapies Recent Development
10.15 AGC Biologics
10.15.1 AGC Biologics Company Details
10.15.2 AGC Biologics Business Overview
10.15.3 AGC Biologics Cell and Gene Therapy CDMO Introduction
10.15.4 AGC Biologics Revenue in Cell and Gene Therapy CDMO Business (2018-2023)
10.15.5 AGC Biologics Recent Development
10.16 Pfizer CentreOne
10.16.1 Pfizer CentreOne Company Details
10.16.2 Pfizer CentreOne Business Overview
10.16.3 Pfizer CentreOne Cell and Gene Therapy CDMO Introduction
10.16.4 Pfizer CentreOne Revenue in Cell and Gene Therapy CDMO Business (2018-2023)
10.16.5 Pfizer CentreOne Recent Development
10.17 Almac Group
10.17.1 Almac Group Company Details
10.17.2 Almac Group Business Overview
10.17.3 Almac Group Cell and Gene Therapy CDMO Introduction
10.17.4 Almac Group Revenue in Cell and Gene Therapy CDMO Business (2018-2023)
10.17.5 Almac Group Recent Development
10.18 PCI Pharma Services
10.18.1 PCI Pharma Services Company Details
10.18.2 PCI Pharma Services Business Overview
10.18.3 PCI Pharma Services Cell and Gene Therapy CDMO Introduction
10.18.4 PCI Pharma Services Revenue in Cell and Gene Therapy CDMO Business (2018-2023)
10.18.5 PCI Pharma Services Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List of Figure

List of Tables
Table 1. Cell and Gene Therapy CDMO Market Size India VS Global, CAGR (2018 VS 2022 VS 2033)
Table 2. Cell and Gene Therapy CDMO Market Trends
Table 3. Cell and Gene Therapy CDMO Market Drivers
Table 4. Cell and Gene Therapy CDMO Market Challenges
Table 5. Cell and Gene Therapy CDMO Market Restraints
Table 6. Global Cell and Gene Therapy CDMO Market Size by Type: 2018 VS 2022 VS 2033 (US$ Million)
Table 7. India Cell and Gene Therapy CDMO Market Size by Type: 2018 VS 2022 VS 2033 (US$ Million)
Table 8. Global Cell and Gene Therapy CDMO Market Size by Application: 2018 VS 2022 VS 2033 (US$ Million)
Table 9. India Cell and Gene Therapy CDMO Market Size by Application: 2018 VS 2022 VS 2033 (US$ Million)
Table 10. Global Key Companies of Cell and Gene Therapy CDMO, Ranked by Revenue (2022) & (US$ Million)
Table 11. Global Cell and Gene Therapy CDMO Revenue by Player, (US$ Million), 2018-2023
Table 12. Global Cell and Gene Therapy CDMO Revenue Share by Player, 2018-2023
Table 13. Global Cell and Gene Therapy CDMO Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Cell and Gene Therapy CDMO by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy CDMO as of 2022)
Table 15. Global Key Players of Cell and Gene Therapy CDMO, Headquarters and Area Served
Table 16. Global Key Players of Cell and Gene Therapy CDMO, Product and Application
Table 17. Global Key Players of Cell and Gene Therapy CDMO, Date of Enter into This Industry
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Key Players of Cell and Gene Therapy CDMO in India, Ranked by Revenue (2022) & (US$ Million)
Table 20. India Cell and Gene Therapy CDMO Revenue by Players, (US$ Million), 2021, 2022 & 2023
Table 21. India Cell and Gene Therapy CDMO Revenue Share by Players, 2021, 2022 & 2023
Table 22. Global Cell and Gene Therapy CDMO Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 23. Global Cell and Gene Therapy CDMO Market Size by Region (2018-2023) & (US$ Million)
Table 24. Global Cell and Gene Therapy CDMO Market Size Forecast by Region (2024-2033) & (US$ Million)
Table 25. Americas Cell and Gene Therapy CDMO Market Size by Type (2018-2023) & (US$ Million)
Table 26. Americas Cell and Gene Therapy CDMO Market Size by Type (2024-2033) & (US$ Million)
Table 27. Americas Cell and Gene Therapy CDMO Market Size by Application (2018-2023) & (US$ Million)
Table 28. Americas Cell and Gene Therapy CDMO Market Size by Application (2024-2033) & (US$ Million)
Table 29. Americas Cell and Gene Therapy CDMO Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 30. Americas Cell and Gene Therapy CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 31. Americas Cell and Gene Therapy CDMO Market Size by Country (2024-2033) & (US$ Million)
Table 32. EMEA Cell and Gene Therapy CDMO Market Size by Type (2018-2023) & (US$ Million)
Table 33. EMEA Cell and Gene Therapy CDMO Market Size by Type (2024-2033) & (US$ Million)
Table 34. EMEA Cell and Gene Therapy CDMO Market Size by Application (2018-2023) & (US$ Million)
Table 35. EMEA Cell and Gene Therapy CDMO Market Size by Application (2024-2033) & (US$ Million)
Table 36. EMEA Cell and Gene Therapy CDMO Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. EMEA Cell and Gene Therapy CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 38. EMEA Cell and Gene Therapy CDMO Market Size by Country (2024-2033) & (US$ Million)
Table 39. China Cell and Gene Therapy CDMO Market Size by Type (2018-2023) & (US$ Million)
Table 40. China Cell and Gene Therapy CDMO Market Size by Type (2024-2033) & (US$ Million)
Table 41. China Cell and Gene Therapy CDMO Market Size by Application (2018-2023) & (US$ Million)
Table 42. China Cell and Gene Therapy CDMO Market Size by Application (2024-2033) & (US$ Million)
Table 43. China Cell and Gene Therapy CDMO Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. APAC Cell and Gene Therapy CDMO Market Size by Type (2018-2023) & (US$ Million)
Table 45. APAC Cell and Gene Therapy CDMO Market Size by Type (2024-2033) & (US$ Million)
Table 46. APAC Cell and Gene Therapy CDMO Market Size by Application (2018-2023) & (US$ Million)
Table 47. APAC Cell and Gene Therapy CDMO Market Size by Application (2024-2033) & (US$ Million)
Table 48. APAC Cell and Gene Therapy CDMO Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 49. APAC Cell and Gene Therapy CDMO Market Size by Region (2018-2023) & (US$ Million)
Table 50. APAC Cell and Gene Therapy CDMO Market Size by Region (2024-2033) & (US$ Million)
Table 51. Lonza Company Details
Table 52. Lonza Business Overview
Table 53. Lonza Cell and Gene Therapy CDMO Product
Table 54. Lonza Revenue in Cell and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 55. Lonza Recent Development
Table 56. Charles River Laboratories Company Details
Table 57. Charles River Laboratories Business Overview
Table 58. Charles River Laboratories Cell and Gene Therapy CDMO Product
Table 59. Charles River Laboratories Revenue in Cell and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 60. Charles River Laboratories Recent Development
Table 61. Cytiva Company Details
Table 62. Cytiva Business Overview
Table 63. Cytiva Cell and Gene Therapy CDMO Product
Table 64. Cytiva Revenue in Cell and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 65. Cytiva Recent Development
Table 66. Catalent Biologics Company Details
Table 67. Catalent Biologics Business Overview
Table 68. Catalent Biologics Cell and Gene Therapy CDMO Product
Table 69. Catalent Biologics Revenue in Cell and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 70. Catalent Biologics Recent Development
Table 71. FUJIFILM Diosynth Biotechnologies Company Details
Table 72. FUJIFILM Diosynth Biotechnologies Business Overview
Table 73. FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy CDMO Product
Table 74. FUJIFILM Diosynth Biotechnologies Revenue in Cell and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 75. FUJIFILM Diosynth Biotechnologies Recent Development
Table 76. BioCentriq Company Details
Table 77. BioCentriq Business Overview
Table 78. BioCentriq Cell and Gene Therapy CDMO Product
Table 79. BioCentriq Revenue in Cell and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 80. BioCentriq Recent Development
Table 81. RoslinCT Company Details
Table 82. RoslinCT Business Overview
Table 83. RoslinCT Cell and Gene Therapy CDMO Product
Table 84. RoslinCT Revenue in Cell and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 85. RoslinCT Recent Development
Table 86. Thermo Scientific Company Details
Table 87. Thermo Scientific Business Overview
Table 88. Thermo Scientific Cell and Gene Therapy CDMO Product
Table 89. Thermo Scientific Revenue in Cell and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 90. Thermo Scientific Recent Development
Table 91. Mesoblast Company Details
Table 92. Mesoblast Business Overview
Table 93. Mesoblast Cell and Gene Therapy CDMO Product
Table 94. Mesoblast Revenue in Cell and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 95. Mesoblast Recent Development
Table 96. Cellularity Company Details
Table 97. Cellularity Business Overview
Table 98. Cellularity Cell and Gene Therapy CDMO Product
Table 99. Cellularity Revenue in Cell and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 100. Cellularity Recent Development
Table 101. Bluebird Bio Company Details
Table 102. Bluebird Bio Business Overview
Table 103. Bluebird Bio Cell and Gene Therapy CDMO Product
Table 104. Bluebird Bio Revenue in Cell and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 105. Bluebird Bio Recent Development
Table 106. Editas Medicine Company Details
Table 107. Editas Medicine Business Overview
Table 108. Editas Medicine Cell and Gene Therapy CDMO Product
Table 109. Editas Medicine Revenue in Cell and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 110. Editas Medicine Recent Development
Table 111. Andelyn Biosciences Company Details
Table 112. Andelyn Biosciences Business Overview
Table 113. Andelyn Biosciences Cell and Gene Therapy CDMO Product
Table 114. Andelyn Biosciences Revenue in Cell and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 115. Andelyn Biosciences Recent Development
Table 116. Wuxi Advanced Therapies Company Details
Table 117. Wuxi Advanced Therapies Business Overview
Table 118. Wuxi Advanced Therapies Cell and Gene Therapy CDMO Product
Table 119. Wuxi Advanced Therapies Revenue in Cell and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 120. Wuxi Advanced Therapies Recent Development
Table 121. AGC Biologics Company Details
Table 122. AGC Biologics Business Overview
Table 123. AGC Biologics Cell and Gene Therapy CDMO Product
Table 124. AGC Biologics Revenue in Cell and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 125. AGC Biologics Recent Development
Table 126. Pfizer CentreOne Company Details
Table 127. Pfizer CentreOne Business Overview
Table 128. Pfizer CentreOne Cell and Gene Therapy CDMO Product
Table 129. Pfizer CentreOne Revenue in Cell and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 130. Pfizer CentreOne Recent Development
Table 131. Almac Group Company Details
Table 132. Almac Group Business Overview
Table 133. Almac Group Cell and Gene Therapy CDMO Product
Table 134. Almac Group Revenue in Cell and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 135. Almac Group Recent Development
Table 136. PCI Pharma Services Company Details
Table 137. PCI Pharma Services Business Overview
Table 138. PCI Pharma Services Cell and Gene Therapy CDMO Product
Table 139. PCI Pharma Services Revenue in Cell and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 140. PCI Pharma Services Recent Development
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Cell and Gene Therapy CDMO Product Picture
Figure 2. Global Cell and Gene Therapy CDMO Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global Cell and Gene Therapy CDMO Market Size 2018-2033 (US$ Million)
Figure 4. India Cell and Gene Therapy CDMO Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 5. India Cell and Gene Therapy CDMO Market Size 2018-2033 (US$ Million)
Figure 6. India Cell and Gene Therapy CDMO Market Share in Global 2018-2033
Figure 7. Cell and Gene Therapy CDMO Report Years Considered
Figure 8. Product Picture of Clinical Trial Material CDMOs
Figure 9. Product Picture of Development and Manufacturing CDMOs
Figure 10. Product Picture of Other
Figure 11. Global Cell and Gene Therapy CDMO Market Share by Type in 2022 & 2033
Figure 12. Global Cell and Gene Therapy CDMO Market Size by Type (2018-2033) & (US$ Million)
Figure 13. Global Cell and Gene Therapy CDMO Market Share by Type (2018-2033)
Figure 14. India Cell and Gene Therapy CDMO Market Share by Type in 2022 & 2033
Figure 15. India Cell and Gene Therapy CDMO Market Size by Type (2018-2033) & (US$ Million)
Figure 16. India Cell and Gene Therapy CDMO Market Share by Type (2018-2033)
Figure 17. Product Picture of Pharmaceutical Company
Figure 18. Product Picture of Biotechnology Company
Figure 19. Product Picture of Other
Figure 20. Global Cell and Gene Therapy CDMO Market Share by Application in 2022 & 2033
Figure 21. Global Cell and Gene Therapy CDMO Market Size by Application (2018-2033) & (US$ Million)
Figure 22. Global Cell and Gene Therapy CDMO Market Share by Application (2018-2033)
Figure 23. India Cell and Gene Therapy CDMO Market Share by Application in 2022 & 2033
Figure 24. India Cell and Gene Therapy CDMO Market Size by Application (2018-2033) & (US$ Million)
Figure 25. India Cell and Gene Therapy CDMO Market Share by Application (2018-2033)
Figure 26. The Top 5 and 10 Largest Companies of Cell and Gene Therapy CDMO in the World: Market Share by Cell and Gene Therapy CDMO Revenue in 2022
Figure 27. Global Cell and Gene Therapy CDMO Market Size Market Share by Region: 2018 VS 2022 VS 2033
Figure 28. Global Cell and Gene Therapy CDMO Market Share by Region (2018-2033)
Figure 29. Americas Cell and Gene Therapy CDMO Market Size Growth Rate 2018-2033 (US$ Million)
Figure 30. Americas Cell and Gene Therapy CDMO Market Share by Type (2018-2033)
Figure 31. Americas Cell and Gene Therapy CDMO Market Share by Application (2018-2033)
Figure 32. United States Cell and Gene Therapy CDMO Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 33. Canada Cell and Gene Therapy CDMO Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 34. Mexico Cell and Gene Therapy CDMO Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 35. Brazil Cell and Gene Therapy CDMO Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 36. EMEA Cell and Gene Therapy CDMO Market Size Growth Rate 2018-2033 (US$ Million)
Figure 37. EMEA Cell and Gene Therapy CDMO Market Share by Type (2018-2033)
Figure 38. EMEA Cell and Gene Therapy CDMO Market Share by Application (2018-2033)
Figure 39. Europe Cell and Gene Therapy CDMO Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 40. Middle East Cell and Gene Therapy CDMO Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 41. Africa Cell and Gene Therapy CDMO Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 42. China Cell and Gene Therapy CDMO Market Size Growth Rate 2018-2033 (US$ Million)
Figure 43. China Cell and Gene Therapy CDMO Market Share by Type (2018-2033)
Figure 44. China Cell and Gene Therapy CDMO Market Share by Application (2018-2033)
Figure 45. APAC Cell and Gene Therapy CDMO Market Size Growth Rate 2018-2033 (US$ Million)
Figure 46. APAC Cell and Gene Therapy CDMO Market Share by Type (2018-2033)
Figure 47. APAC Cell and Gene Therapy CDMO Market Share by Application (2018-2033)
Figure 48. Japan Cell and Gene Therapy CDMO Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 49. South Korea Cell and Gene Therapy CDMO Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 50. China Taiwan Cell and Gene Therapy CDMO Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 51. Southeast Asia Cell and Gene Therapy CDMO Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 52. India Cell and Gene Therapy CDMO Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 53. Lonza Revenue Growth Rate in Cell and Gene Therapy CDMO Business (2018-2023)
Figure 54. Charles River Laboratories Revenue Growth Rate in Cell and Gene Therapy CDMO Business (2018-2023)
Figure 55. Cytiva Revenue Growth Rate in Cell and Gene Therapy CDMO Business (2018-2023)
Figure 56. Catalent Biologics Revenue Growth Rate in Cell and Gene Therapy CDMO Business (2018-2023)
Figure 57. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Cell and Gene Therapy CDMO Business (2018-2023)
Figure 58. BioCentriq Revenue Growth Rate in Cell and Gene Therapy CDMO Business (2018-2023)
Figure 59. RoslinCT Revenue Growth Rate in Cell and Gene Therapy CDMO Business (2018-2023)
Figure 60. Thermo Scientific Revenue Growth Rate in Cell and Gene Therapy CDMO Business (2018-2023)
Figure 61. Mesoblast Revenue Growth Rate in Cell and Gene Therapy CDMO Business (2018-2023)
Figure 62. Cellularity Revenue Growth Rate in Cell and Gene Therapy CDMO Business (2018-2023)
Figure 63. Bluebird Bio Revenue Growth Rate in Cell and Gene Therapy CDMO Business (2018-2023)
Figure 64. Editas Medicine Revenue Growth Rate in Cell and Gene Therapy CDMO Business (2018-2023)
Figure 65. Andelyn Biosciences Revenue Growth Rate in Cell and Gene Therapy CDMO Business (2018-2023)
Figure 66. Wuxi Advanced Therapies Revenue Growth Rate in Cell and Gene Therapy CDMO Business (2018-2023)
Figure 67. AGC Biologics Revenue Growth Rate in Cell and Gene Therapy CDMO Business (2018-2023)
Figure 68. Pfizer CentreOne Revenue Growth Rate in Cell and Gene Therapy CDMO Business (2018-2023)
Figure 69. Almac Group Revenue Growth Rate in Cell and Gene Therapy CDMO Business (2018-2023)
Figure 70. PCI Pharma Services Revenue Growth Rate in Cell and Gene Therapy CDMO Business (2018-2023)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed